|
Zinc Chemoprevention of Arsenic Co-Carcinogenesis
|
5R01CA182969-04
|
$314,363
|
|
HUDSON, LAURIE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Yale SPORE in Skin Cancer
|
3P50CA121974-10S1
|
$25,000
|
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
Yale SPORE in Skin Cancer
|
3P50CA121974-10S2
|
$709,079
|
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$741,267
|
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Workshop on Methods in Supportive Oncology Research
|
5R25CA181000-04
|
$309,257
|
|
TEMEL, JENNIFER
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Work Ability in Young Adult Surviviors (WAYS): A Quantitative Investigation
|
5R21CA191989-02
|
$168,563
|
|
DANHAUER, SUZANNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-05
|
$2,260,718
|
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
WNT4 IN ENDOCRINE RESPONSE AND RESISTANCE IN INVASIVE LOBULAR CARCINOMA
|
4R00CA193734-03
|
$249,000
|
|
SIKORA, MATTHEW
|
UNIVERSITY OF COLORADO DENVER
|
|
WESTAT- GLOBAL SUPPORT FOR BRP DATA ANALYSIS ACTIVITIES
|
261201200028I
|
$1,056,561
|
|
UNKNOWN, UNKNOWN
|
WESTAT INCORPORATED
|
|
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
|
1P50CA211024-01A1
|
$2,184,999
|
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
|
5R01CA210125-02
|
$656,491
|
|
WOODALL, W
|
KLEIN BUENDEL, INC.
|
|
Water Soluble Polymers to Target Tumor-Associated Extracellular Matrix for Delivery of MMP Inhibitors
|
1F31CA213901-01A1
|
$44,044
|
|
SUBRAHMANYAM, NITHYA
|
UNIVERSITY OF UTAH
|
|
Washington University PDX Development and Trial Center
|
1U54CA224083-01
|
$2,424,750
|
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
Wake Forest NCORP Research Base
|
3UG1CA189824-04S1
|
$189,075
|
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Wake Forest NCORP Research Base
|
5UG1CA189824-04
|
$3,481,450
|
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Viruses and Cancer
|
2T32CA060395-21A1
|
$224,723
|
|
MEYERS, CRAIG
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Viral Oncology Training Grant
|
3T32CA009111-38S1
|
$13,628
|
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-03
|
$332,363
|
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Vermont Breast Cancer Molecular Characterization Laboratory
|
3U01CA196383-03S1
|
$312,000
|
|
STEIN, JANET
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
VEGF signaling in Mammary Tumorigenesis
|
2R01CA168464-06
|
$397,813
|
|
MERCURIO, ARTHUR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
5R01CA184456-02
|
$341,981
|
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,151,796
|
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Vangl Dependent PCP Signaling Mediates EMT Induced Cell Invasiveness
|
5F31CA210467-02
|
$38,596
|
|
VANDERVORST, KACEY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Vanderbilt Training Program in Molecular and Genetic Epidemiology of Cancer
|
2T32CA160056-07
|
$403,151
|
|
SHU, XIAO-OU
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
5UH2CA206124-02
|
$248,101
|
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Validation and Development of WEE1 as a therapeutic target in AML
|
7R01CA172385-05
|
$323,700
|
|
PORTER, CHRISTOPHER
|
EMORY UNIVERSITY
|
|
Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics
|
5R33CA177333-04
|
$298,354
|
|
FEDERSPIEL, MARK
|
MAYO CLINIC ROCHESTER
|
|
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
|
5R33CA196470-02
|
$390,115
|
|
LIN, QIAO
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Validating and Characterizing a New Melanoma Therapeutic Target
|
1R01CA217625-01
|
$646,803
|
|
COURTNEIDGE, SARA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$465,962
|
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$465,962
|
|
Hodge, James
|
CCR (NCI)
|
|
UW Radiological Sciences Training Program
|
5T32CA009206-39
|
$488,926
|
|
HALL, TIMOTHY
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-03S1
|
$50,000
|
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Using Technology to Scale-Up an Occupational Sun Protection Policy Program
|
1R01CA210259-01A1
|
$682,639
|
|
BULLER, DAVID
|
KLEIN BUENDEL, INC.
|
|
Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients
|
5R01CA193706-02
|
$556,045
|
|
WYATT, GWEN
|
MICHIGAN STATE UNIVERSITY
|
|
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
|
1R21CA216756-01
|
$187,050
|
|
SMALLEY, KEIRAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Using markers to improve pancreatic cancer screening and surveillance
|
5U01CA210170-02
|
$953,081
|
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Using hunger training to enhance weight loss and modulate cancer-related biomarkers in women at high risk for breast cancer: a pilot study
|
1R21CA215415-01A1
|
$208,800
|
|
SCHEMBRE, SUSAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness
|
5R21CA201865-02
|
$179,438
|
|
LIANG, GANGNING
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Using Context to Improve Implementation of Evidenced-based Interventions for Colorectal Cancer Screening in Rural Primary Care (Precise CRC)
|
1K07CA211971-01A1
|
$170,639
|
|
DAVIS, MELINDA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Using Big Data to Estimate the Effects of Complex Cost-Sharing Rules on Colorectal Cancer Screening and Patient Health
|
1R21CA219229-01
|
$208,522
|
|
WHALEY, CHRISTOPHER
|
RAND CORPORATION
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$27,615
|
|
Merlino, Glenn
|
CCR (NCI)
|
|
Unraveling resistance to PI3K-alpha inhibitors in breast cancer
|
5R01CA190642-03
|
$436,922
|
|
BASELGA, JOSE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade
|
5R21CA208609-02
|
$174,000
|
|
PATEL, SAPNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of Texas PDX Development and Trial Center
|
1U54CA224065-01
|
$2,561,686
|
|
ROTH, JACK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of Michigan Surgical Oncology Research Training Program
|
5T32CA009672-27
|
$206,509
|
|
ZOU, WEIPING
|
UNIVERSITY OF MICHIGAN
|
|
Uniting Mass Spectrometry and Glycoscience to Investigate Cancer Biology
|
5F99CA212454-02
|
$32,109
|
|
RILEY, NICHOLAS
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
|
3R01CA181633-04S1
|
$69,420
|
|
WITZE, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
Total relevant funding to Gene Therapy Clinical Trials for this search: $8,314,731
|